IMPA2 抗体 (AA 146-195)
Quick Overview for IMPA2 抗体 (AA 146-195) (ABIN6739072)
抗原
See all IMPA2 抗体适用
宿主
克隆类型
标记
应用范围
-
-
抗原表位
- AA 146-195
-
特异性
- Human IMPA2
-
预测反应
- Percent identity by BLAST analysis: Human, Bovine (100%) Dog (92%) Horse (85%) Rabbit (84%).
-
纯化方法
- Immunoaffinity purified
-
免疫原
-
Synthetic peptide located between aa146-195 of human IMPA2 (O14732, NP_055029). Percent identity by BLAST analysis: Human, Chimpanzee, Gorilla, Gibbon, Monkey, Bovine (100%), Dog, Bat (92%), Marmoset (86%), Horse, Opossum, Guinea pig, Platypus (85%), Rabbit (84%).
Type of Immunogen: Synthetic peptide -
亚型
- IgG
-
-
anti-Inositol(myo)-1(or 4)-Monophosphatase 2 (IMPA2) (AA 1-288) antibody
IMPA2 适用: 人 WB, IHC (p) 宿主: 小鼠 Polyclonal unconjugated
anti-Inositol(myo)-1(or 4)-Monophosphatase 2 (IMPA2) (AA 48-82) antibodyIMPA2 适用: 人 WB 宿主: 兔 Polyclonal RB53375 unconjugated
anti-Inositol(myo)-1(or 4)-Monophosphatase 2 (IMPA2) (AA 1-288) antibodyIMPA2 适用: 人 WB 宿主: 兔 Polyclonal unconjugated
anti-Inositol(myo)-1(or 4)-Monophosphatase 2 (IMPA2) antibodyIMPA2 适用: 人 WB 宿主: 兔 Polyclonal unconjugated
anti-Inositol(myo)-1(or 4)-Monophosphatase 2 (IMPA2) (C-Term) antibodyIMPA2 适用: 人, 小鼠, 大鼠, Cow, 马, 兔, 犬, 豚鼠, 斑马鱼 WB 宿主: 兔 Polyclonal unconjugated
anti-Inositol(myo)-1(or 4)-Monophosphatase 2 (IMPA2) (Middle Region) antibodyIMPA2 适用: 人, 小鼠, 大鼠, Cow, 马, 兔, 犬, 豚鼠 WB 宿主: 兔 Polyclonal unconjugated
-
-
应用备注
-
Approved: WB
Usage: ELISA titer using peptide based assay: 1:312500. Western Blot: Suggested dilution at 1 μg/mL in 5 % skim milk / PBS buffer, and HRP conjugated anti-Rabbit IgG should be diluted in 1:50000 - 100000 as second antibody. -
说明
-
Target Species of Antibody: Human
-
限制
- 仅限研究用
-
-
-
状态
- Lyophilized
-
溶解方式
- Distilled Water.
-
浓度
- Lot specific
-
缓冲液
- Lyophilized from PBS with 2 % sucrose
-
注意事项
- Avoid repeat freeze-thaw cycles.
-
储存条件
- 4 °C,-20 °C
-
储存方法
-
Long term: -20°C, the use of 50% glycerol is recommended if storing aliquots in -20°C for long term use (up to 1 year)
Short term (less than 1 week): 4°C. Avoid freeze-thaw cycles.
-
-
-
